Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) EBT (2016 - 2025)

Apyx Medical's EBT history spans 15 years, with the latest figure at -$1.1 million for Q4 2025.

  • For Q4 2025, EBT rose 83.69% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached -$10.8 million, up 57.94%, while the annual FY2025 figure was -$10.8 million, 57.94% up from the prior year.
  • EBT reached -$1.1 million in Q4 2025 per APYX's latest filing, up from -$1.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$953000.0 in Q2 2023 to a low of -$9.5 million in Q4 2023.
  • Average EBT over 5 years is -$4.8 million, with a median of -$4.9 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 585.83% in 2024, then surged 83.69% in 2025.
  • A 5-year view of EBT shows it stood at -$1.9 million in 2021, then plummeted by 215.25% to -$5.9 million in 2022, then plummeted by 61.26% to -$9.5 million in 2023, then grew by 26.34% to -$7.0 million in 2024, then soared by 83.69% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's EBT are -$1.1 million (Q4 2025), -$1.9 million (Q3 2025), and -$3.7 million (Q2 2025).